Search results for "kings college london"

The team will also discuss evidence strategies for 510(k), De Novo, and PMA programs, as well as SitePath™ site operations function and TrialPathDx™ Clinical Trial Management System

O-Cyte 1 is an AI-powered hematology analyzer that combines morphology intelligence with scalable laboratory throughput

Collaboration, clinical innovation, and the real-world impact of AI

Discover how structured collaboration with a contract development and manufacturing organization (CDMO) supports better early engineering decisions

Mindray and Thermo Fisher Scientific among those recognized

Siemens Healthineers will unveil innovations designed to optimize strategic impact, along with new research conducted by YouGov

Fapon debuts AI-engineered molecular diagnostic enzymes and Alzheimer's disease assay solutions while expanding its North American IVD footprint

New U.S. business will combine automated diagnostic kit manufacturing, fulfillment, logistics and digital pathway technology to help laboratories and healthcare organizations scale testing programs

Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volumes, introducing a step-change in analytical performance for complex biological matrices

Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics

Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical needs with reliable, purpose-built diagnostic and workflow solutions

Alps Dx introduces Xpressor™, a filtration and capping solution designed to simplify oral fluid sample preparation and improve preanalytical consistency

AI, precision diagnostics, and award-winning innovation take center stage

bioMérieux to showcase integrated microbiology, molecular diagnostics, mass spectrometry, and laboratory informatics solutions

At AAIC 2026, Dr. Ashton Harper, Roche Diagnostics, discusses how pTau217 could help reshape Alzheimer’s testing across primary and secondary care

G&H will highlight end-to-end diagnostic instrument development, photonics integration, and ISO 13485-certified manufacturing for next-generation IVDs and medical devices